BRCA1 Genetic Mutation and Its Link to Ovarian Cancer: Implications for Advanced Practice Nurses
- 1 December 2005
- journal article
- review article
- Published by Wiley in Journal of the American Academy of Nurse Practitioners
- Vol. 17 (12) , 518-526
Abstract
The purpose of this paper is to review (a) the linkage between the BRCA1 gene and ovarian cancer and (b) BRCA1 testing and its related issues. This review is aimed for nurse practitioners (NPs), who may be in positions to identify those at risk for BRCA1-associated ovarian cancer and to assist patients with related issues. Data sources include reviews and original research from scholarly journals and Internet sites. Ovarian cancer is a deadly disease. Identification of those at risk because of BRCA1 mutation is possible through genetic testing. Testing for BRCA1 gene mutations has many implications whether results are positive or negative. Those with positive results will be faced with decisions regarding the best management strategies. Negative results do not completely eliminate ovarian cancer risk. Current management options for carriers of the BRCA1 mutation include taking no action, increasing surveillance for ovarian cancer, and chemoprevention with oral contraceptives or prophylactic oophorectomy for those who have completed childbearing. It is essential that NPs have knowledge underlying the issues and concerns of patients and their families at risk for BRCA1-associated ovarian cancer. NPs are in a unique position to help identify BRCA1 mutation carriers and to assist them and their families with the complex issues involving genetic testing and management options. Understanding these issues will allow NPs to give appropriate care that may include making appropriate referrals to certified genetic counselors and having balanced discussions on treatment options. Such measurements may improve early diagnosis of ovarian cancer and increase survival from this disease.Keywords
This publication has 49 references indexed in Scilit:
- Ovarian Cancer: Early Symptom PatternsOncology Nursing Forum, 2003
- Survival and prognostic factors in patients with ovarian cancerObstetrics & Gynecology, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Interest in BRCA1/2 Testing in a Primary Care PopulationPreventive Medicine, 2002
- Human Genomics: Challenges and OpportunitiesJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2002
- Long-Term Follow-up of the Stockholm Screening Study on Ovarian CancerGynecologic Oncology, 2000
- Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancerPsycho-Oncology, 2000
- A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomyPsycho-Oncology, 2000
- Reported ovarian cancer screening among a population-based sample in Washington stateObstetrics & Gynecology, 2000
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerThe American Journal of Human Genetics, 2000